Literature DB >> 30021347

RETRACTED: miR-149 regulates the proliferation and apoptosis of cervical cancer cells by targeting GIT1.

Bing Qian1, LiJun Zhao1, XiaoFang Wang1, Juan Xu2, Fang Teng2, LingJuan Gao3, Rong Shen4.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Authors. The authors have found that the Western Blot result of cyclin D1 in Figure 3C cannot be repeated using the same method and requested that their paper be retracted.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Apoptosis; Cervical cancer; GIT1; PI3K/AKT/mTOR pathway; Proliferation; miR-149

Mesh：

Substances：

Year:  2018        PMID： 30021347     DOI： 10.1016/j.biopha.2018.06.075

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN： 0753-3322            Impact factor:   6.529


  4 in total

Review 1.  Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health.

Authors:  Michela Lucia Sammarco; Manuela Tamburro; Alessandra Pulliero; Alberto Izzotti; Giancarlo Ripabelli
Journal:  Microrna       Date:  2020

2.  Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.

Authors:  Iris Babion; Lise M A De Strooper; Roosmarijn Luttmer; Maaike C G Bleeker; Chris J L M Meijer; Daniëlle A M Heideman; Saskia M Wilting; Renske D M Steenbergen
Journal:  Epigenetics       Date:  2019-04-08       Impact factor: 4.528

3.  Long non‑coding RNA BCYRN1 promotes glycolysis and tumor progression by regulating the miR‑149/PKM2 axis in non‑small‑cell lung cancer.

Authors:  Ning Lang; Chunyang Wang; Jiangyang Zhao; Feng Shi; Tong Wu; Hongyan Cao
Journal:  Mol Med Rep       Date:  2020-01-16       Impact factor: 2.952

4.  miR-149 inhibits cell proliferation and enhances chemosensitivity by targeting CDC42 and BCL2 in neuroblastoma.

Authors:  Fengxia Mao; Ju Zhang; Xinru Cheng; Qianya Xu
Journal:  Cancer Cell Int       Date:  2019-12-27       Impact factor: 5.722
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.